De novo synthesis of cardiolipin controls respiratory chain biogenesis in neonatal mouse hearts. [PDF]
Ren M +5 more
europepmc +1 more source
Mitochondrial Quality Control in Inherited Mitochondrial Cardiomyopathy: Convergent Pathobiology and a Testable Therapeutic Framework. [PDF]
Lee CL +9 more
europepmc +1 more source
Cardiolipin as a Signaling Hub: Evolutionary Conservation and Programmable Platforms Coupling Mitochondrial Stress to Cell Fate. [PDF]
Petit PX.
europepmc +1 more source
Barth syndrome (BTHS) is a rare X-linked genetic disease classically characterized by cardiomyopathy, skeletal myopathy, and neutropenia. It is caused by mutations in the TAFAZZIN gene, which codes for the protein tafazzin (Taz), and this results in alterations in the level and molecular composition of the mitochondrial phospholipid cardiolipin with ...
openaire +1 more source
Cardiolipin remodelling in mitochondrial therapeutics: translational evidence chains from elamipretide to emerging strategies. [PDF]
Di K, Hu Y, Sun H, Meng T, Han T, Qie R.
europepmc +1 more source
The molecular mechanisms of crista formation: how mitochondria give themselves breathing room. [PDF]
Colina-Tenorio L +3 more
europepmc +1 more source
Cross-species evidence for cardiolipin remodeling in neonatal hypoxic-ischemic encephalopathy. [PDF]
Emaus KJ +9 more
europepmc +1 more source
Understanding the role of MLCL AT-1 and tafazzin in mitochondrial function
Cardiolipin (CL) is a phospholipid found exclusively in mitochondria and is required for normal mitochondrial function. CL biosynthesis requires a crucial remodelling step that incorporates specific acyl chains onto its molecular structure. The enzyme primarily responsible for CL remodelling is Tafazzin (TAZ), a mitochondrial protein encoded by the TAZ
openaire +1 more source
Metabolic cardiomyopathies: untangling clinical heterogeneity with human stem-cell derived models. [PDF]
Passadouro AS +6 more
europepmc +1 more source

